Reduced anticardiolipin antibodies in first episode and chronic schizophrenia

Psychiatry Research

Volumn 144, Issue 2-3, 2006, Pages 211-216

  Sirota, Pinkhas ^a   Bogdanov, Irene ^a   Katzav, Aviva ^a   Hershko, Ruth ^a   Chapman, Joab ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anticardiolipin antibodies; Autoimmunity; First episode schizophrenia; Immune system; Schizophrenia

Indexed keywords

CARDIOLIPIN; CARDIOLIPIN ANTIBODY;

ACUTE PHASE RESPONSE; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; BIPOLAR DISORDER; CHRONIC DISEASE; CONTROLLED STUDY; COW; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SERUM; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ADULT; ANTIBODIES, ANTICARDIOLIPIN; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; TIME FACTORS;

EID: 33750507888     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2006.02.002     Document Type: Article

References (28)

1. Alarcón-Segovia D. Pathogenic potential of antiphospholipid antibodies. Journal of Rheumatology 15 (1989) 890-893
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), APA, Washington, DC
3. Asherson R.A. Antiphospholipid antibodies and "syndromes", many questions and few answers. Israel Journal of Medical Sciences 26 (1990) 284-286
4. Canoso R.T., and Sise H.S. Chloropromazine-induced lupus anticoagulant and associated immunologic abnormalities. American Journal of Hematology 113 (1982) 121-125
5. Canoso R.T., de Oliveira R.M., and Nixon R.A. Nueroleptic-associated autoantibodies. A prevalence study. Biological Psychiatry 27 (1990) 863-888
6. Chengappa K.N.R., Carpenter A.B., Keshavan M.S., Yang Z.W., Kelly R.H., Rabin B.S., and Ganguli R. Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients. Biological Psyhchiatry 30 (1991) 731-735
7. Drenkard C., Sánchez-Guerrero J., and Alarcón-Segovia D. Fall in antiphospholipid antibody at time of thromboocclusive episode in systemic lupus erythematosus. Journal of Rheumatology 16 (1989) 614-617
8. Firer M., Sirota P., Schild K., Elizur A., and Slor H. Anticardiolipin antibodies are elevated in drug free, multiply affected families with schizophrenia. Journal of Clinical Immunology 14 (1994) 73-78
9. Galli M., Comfurius P., and Maassen C. Anticardiolipin antibodies (ACA) directed not to cartiolipin but to a plasma protein cofactor. Lancet 336 (1990) 177-178
10. Ganguli R., Rasin B.S., and Kelly R.H. Multiple autoantibodies and autoimmune disease in schizophrenic patients: evidence for an autoimmune pathogenesis. In: Hadden J.W., Masek K., and Nistico G. (Eds). Interactions Among CNS, Neurendocrine and Immune Systems (1989), Pythagora Press 365
11. Gordesky S.B., and Martinetti G.V. The asymmetric arrangement of phospholipids in the human erythrocyte membrane. Biochemical and Biophysical Research Communications 50 (1973) 1027-1031
12. Harris E.N. The Second International Anti-Cardiolipin Standardization Workshop/The Kingston Antiphospholipid Antibody Study (KAPS) Group. American Journal of Clinical Pathology 94 (1990) 476-484
13. Harris E.N., Gharavi A.G., Patel S.P., and Hughes G.R.V. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clinical and Experimental Immunology 68 (1987) 215-222
14. Harris E.N., Asherson R.A., and Hughes G.R.V. Anitphospholipid antibodies: autoantibodies with a difference. Annual Review of Medicine 39 (1988) 261-271
15. Harris E.N., Pierangeli S., Barquinero J., and Ordi-Ros J. Anti-cardiolipin antibodies and binding of anionic phospholipids and serum protein. Lancet 336 (1990) 505-506
16. Maes M., Bosmans E., Suy E., Vandervorst C., Dejonckheere C., and Raus J. Antiphospholipid, antinuclear, Epstein-Barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients. Journal of Affective Disorders 21 (1991) 133-140
17. McNeil H.P., Simpson R.J., Chesterman C.N., and Krillis S.A. Antiphospho-lipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein 1 (apolipoprotein H). Proceedings of the National Academy of Sciences of the United States of America 87 (1990) 4120-4124
18. McNeil H.P., Hunt J.E., and Krilis S.A. Antiphospholipid antibodies - new insights into their specificity and clinical importance. Scandinavian Journal of Immunology 36 (1992) 647-652
19. Sammaritano L.R., Gharavi A.G., and Lockshin M.D. Antiphospholipid syndrome: immunological and clinical aspects. Seminars. Arthritis and Rheumatism 20 (1990) 81-88
20. Schick P.K., Kurika K.B., and Chacko C.K. Location of phosphatidylehtanolamine and phosphatidylserine in the human platelet plasma membrane. Journal of Clinical Investigation 57 (1976) 1221-1226
21. Sirota P. Is schizophrenia an autoimmune disease?. Israel Journal of Medical Sciences 26 (1990) 694-697
22. Sirota P., Firer M.A., Schild K., Barak Y., Zurgil N., Elizur A., and Sior H. Increased anti-Sm antibodies in schizophrenic patients and their families. Progress in Neuro-Psychopharmacology & Biological Psychiatry 17 (1993) 793-800
23. Sirota P., Firer M.A., Schild K., Barak Y., Zurgil N., Elizur H., and Slor H. Autoantibodies to DNA in multicase families with schizophrenia. Biological Psychiatry 33 (1993) 450-455
24. Sturfelt G., Nived O., Norberg R., Thorstensson R., and Krook K. Anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis and Rheumatism 30 (1987) 382-388
25. Von Brauchitsch H. Antinuclear factor in psychiatric disorders. American Journal of Psychiatry 128 (1972) 4552-4555
26. Yannitsi S.G., Manoussakis M.N., and Mavridis A.K. Factors related to the presence of autoantibodies in patients with chronic mental disorders. Biological Psychiatry 27 (1990) 747-751
27. Zarrabi M.H., Zucker S., and Miller F. Immunologic and coagulation disorders in chlorpromazine treated patients. Annals of Internal Medicine 91 (1979) 194-196
28. Zwaal R.F.A., Comfurious P., and Van Deenen L.L.M. Membrane symmetry and blood coagulation. Nature 268 (1977) 358-360